tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Advertisement

Phathom Pharmaceuticals (PHAT) Revenue

Compare
535 Followers

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had a revenue of 49.50M in the quarter ending Sep 30, 2025, with 25.32%. This bring the company's revenue in the last twelve months to 147.19M, Decreased 29.07%. In the fiscal year ending Dec 31, 2024, Phathom Pharmaceuticals had annual revenue of 55.25M with 8001.47% growth.
Revenue (ttm)
147.19M
Revenue Growth
460.30%
P/S Ratio
17.10
Revenue/Employee
$129,396
Employees
427
Market Cap
$944.72M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
55.25M54.57M+8,101.48%
Dec 31, 2023
682.00K-68,200,000.00%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis